ALTERNATIVE FINANCING FORMS
FOR ENTREPRENEURS AND INVESTORS
FYB Company Profile

TVM Life Science Management GmbH

Otto­straße 4, 80333 München
Phone: +49–89-99 89 92–00 | Cont­act: Dr. Hubert Birner · [email protected]
www.tvm-lifescience.com

Profile

TVM is a leading inter­na­tio­nal venture capi­tal firm focu­sed on investing
in life science inno­va­tions. TVM pursues a unique two-pron­­ged stra­tegy, finan­cing inno­va­tive early-stage thera­peu­tics through a single asset company approach (Project-Focu­­sed Company, PFC), that lever­a­ges the firm’s stra­te­gic rela­ti­onship with global phar­maceu­ti­cal firm, Eli Lilly and Company. TVM also invests in diffe­ren­tia­ted commer­cial-stage medi­cal tech­no­lo­gies and late clini­­cal-stage therapeutics.

Services

TVM actively invests in lasting part­ner­ships provi­ding port­fo­lio compa­nies with what they each need to succeed: recrui­ting new manage­ment and board members, honing deve­lo­p­ment plans and product regis­tra­tion stra­te­gies, finding poten­tial part­ners and carry­ing out finan­cing and exit stra­te­gies. The TVM global network of entre­pre­neurs provi­des manage­ment resour­ces, key opinion leaders and ever­y­day cont­act part­ners and experts for all rele­vant specia­list areas.

Participation

Type of participation
Majority/minority stake
Funding Stages
Venture Capital/Growth Capital
Minimum investment
$ 1 m
Investments
An up-to-date overview can be found on our website.
Capital Managed
About $ 900 m

Company

Management
Dr. Hubert Birner · Dr. Luc Marengere · Stefan Fischer (Finance)
Foundation
1984
Team size
20
Subsidiaries

Subscribe newsletter

Here you can read about the latest transactions, IPOs, private equity deals and venture capital investments, who has raised a new fund, how Buy & Build activities are going.

Get in touch

Contact us!
fyb [at] fyb.de